| Manganese induces oxidative stress, redox state unbalance and disrupts membrane bound ATPases on murine neuroblastoma cells in vitro: protective role of silymarin Y Chtourou, K Trabelsi, H Fetoui, G Mkannez, H Kallel, N Zeghal Neurochemical Research 36, 1546-1557, 2011 | 96 | 2011 |
| Silymarin, a natural antioxidant, protects cerebral cortex against manganese-induced neurotoxicity in adult rats Y Chtourou, H Fetoui, M Sefi, K Trabelsi, M Barkallah, T Boudawara, ... Biometals 23, 985-996, 2010 | 87 | 2010 |
| Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor K Trabelsi, S Rourou, H Loukil, S Majoul, H Kallel Journal of biotechnology 121 (2), 261-271, 2006 | 80 | 2006 |
| A novel animal-component-free medium for rabies virus production in Vero cells grown on Cytodex 1 microcarriers in a stirred bioreactor S Rourou, A van Der Ark, S Majoul, K Trabelsi, T van Der Velden, H Kallel Applied microbiology and biotechnology 85 (1), 53-63, 2009 | 53 | 2009 |
| Development of a measles vaccine production process in MRC-5 cells grown on Cytodex1 microcarriers and in a stirred bioreactor K Trabelsi, S Majoul, S Rourou, H Kallel Applied microbiology and biotechnology 93 (3), 1031-1040, 2012 | 43 | 2012 |
| Comparison of various culture modes for the production of rabies virus by Vero cells grown on microcarriers in a 2-l bioreactor K Trabelsi, S Rourou, H Loukil, S Majoul, H Kallel Enzyme and Microbial Technology 36 (4), 514-519, 2005 | 43 | 2005 |
| Purification of rabies virus produced in Vero cells grown in serum free medium K Trabelsi, MB Zakour, H Kallel Vaccine 37 (47), 7052-7060, 2019 | 29 | 2019 |
| An animal component free medium that promotes the growth of various animal cell lines for the production of viral vaccines S Rourou, YB Ayed, K Trabelsi, S Majoul, H Kallel Vaccine 32 (24), 2767-2769, 2014 | 28 | 2014 |
| Development of a vectored vaccine against hepatitis E virus K Trabelsi, A Kamen, H Kallel Vaccine 32 (24), 2808-2811, 2014 | 20 | 2014 |
| Immunogenicity and efficacy of an in-house developed cell-culture derived veterinarian rabies vaccine H Kallel, MF Diouani, H Loukil, K Trabelsi, MA Snoussi, S Majoul, ... Vaccine 24 (22), 4856-4862, 2006 | 19 | 2006 |
| Establishing a Robust Manufacturing Platform for Recombinant Veterinary Vaccines: An Adenovirus-Vector Vaccine to Control Newcastle Disease Virus Infections of Poultry in Sub … O Farnós, E Gelaye, K Trabelsi, A Bernier, K Subramani, H Kallel, M Yami, ... Vaccines 8 (2), 338, 2020 | 16 | 2020 |
| Development of an in situ detachment protocol of Vero cells grown on Cytodex1 microcarriers under animal component-free conditions in stirred bioreactor S Rourou, N Riahi, S Majoul, K Trabelsi, H Kallel Applied biochemistry and biotechnology 170, 1724-1737, 2013 | 13 | 2013 |
| Process intensification for an enhanced replication of a newly adapted RM-65 sheep pox virus strain in Vero cells grown in stirred bioreactor K Trabelsi, S Majoul, S Rourou, H Kallel Biochemical engineering journal 90, 131-139, 2014 | 12 | 2014 |
| Purification of rabies virus produced on vero cells using chromatography techniques M Chtioui, K Trabelsi, H Kallel Cell Technology for Cell Products: Proceedings of the 19th ESACT Meeting …, 2007 | 5 | 2007 |
| Development of an efficient veterinary rabies vaccine production process in the avian suspension cell line AGE1. CR. pIX K Trabelsi, MB Zakour, I Jordan, V Sandig, S Rourou, H Kallel BMC biotechnology 22 (1), 17, 2022 | 4 | 2022 |
| Production and characterization of a fusion form of hepatitis E virus tORF2 capsid protein in Escherichia coli M Boumaiza, K Trabelsi, Z Choucha, I Akrouti, S Leone, D Picone, ... Preparative Biochemistry & Biotechnology 51 (6), 562-569, 2021 | 4 | 2021 |
| How concerning is a SARS-CoV-2 variant of concern? Computational predictions and the variants labeling system D Ashoor, M Marzouq, K Trabelsi, S Chlif, N Abotalib, NB Khalaf, ... Frontiers in Cellular and Infection Microbiology 12, 868205, 2022 | 3 | 2022 |
| Development of an Optimized Process for Functional Recombinant SARS-CoV-2 Spike S1 Receptor-Binding Domain Protein Produced in the Baculovirus Expression Vector System M Boumaiza, A Chaabene, I Akrouti, M Ben Zakour, H Askri, S Salhi, ... Tropical Medicine and Infectious Disease 8 (11), 501, 2023 | 1 | 2023 |
| A novel approach to designing viral precision vaccines applied to SARS-CoV-2 K Trabelsi, N Ben Khalaf, AR Ramadan, A Elsharkawy, D Ashoor, S Chlif, ... Frontiers in Cellular and Infection Microbiology 14, 1346349, 2024 | | 2024 |
| COVID-19 in Tunisia (North Africa): IgG and IgG subclass antibody responses to SARS-CoV-2 according to disease severity C Benabdessalem, S Marzouki, WB Hamouda, K Trabelsi, M Boumaiza, ... medRxiv, 2022.03. 01.22271696, 2022 | | 2022 |
samia rourouInstitut Pasteur de TunisVerified email at pasteur.rns.tn
